Dr. Reddy'S Formulations Profile
Key Indicators
- Authorised Capital ₹ 20.05 Cr
as on 05-11-2024
- Paid Up Capital ₹ 9.05 Cr
as on 05-11-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth -3.09%
(FY 2023)
- Total Assets %
(FY 2023)
About Dr. Reddy'S Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.05 Cr and a paid-up capital of Rs 9.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Sharma, Venkatanarasimham Mannam, and Manivannan Ganesh serve as directors at the Company.
- CIN/LLPIN
U24299TG2021PLC149527
- Company No.
149527
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2021
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr. Reddy'S Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Sharma  | Director | 11-Mar-2021 | Current |
| Venkatanarasimham Mannam | Director | 11-Mar-2021 | Current |
| Manivannan Ganesh | Director | 12-Jun-2024 | Current |
Financial Performance of Dr. Reddy'S Formulations.
Dr. Reddy'S Formulations Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 3.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr. Reddy'S Formulations?
In 2022, Dr. Reddy'S Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aurigene Pharmaceutical Services LimitedActive 5 years 4 monthsVenkatanarasimham Mannam is a mutual person
Idea2enterprises (India) Private LimitedActive 24 years 7 monthsVenkatanarasimham Mannam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Reddy'S Formulations?
Unlock and access historical data on people associated with Dr. Reddy'S Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Reddy'S Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Reddy'S Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
